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MODERN APPROACHES TO SEPSIS – EVOLVING DEFINITIONS, 
CLINICIAN ROLES AND AI-BASED DIAGNOSTIC AIDS 
JASON MATHIAS 
 
ABSTRACT 
 Sepsis is an ongoing concern in critical care. It is hard to quickly detect, and rapid 
deterioration of a patient into septic shock causes death in around 30% - 50% of patients, 
while survivors may live with organ damage and shorter lifespans. Traditional methods 
of detection require long laboratory tests and clinician vigilance, which put a strain on 
hospital resources.  
 New advances in machine learning offer an alternative – using algorithmic 
analysis in real-time to watch for a deteriorating patient state. The use of readily available 
data – heart rate, respiratory rate – combined with electronic medical records and fast 
laboratory tests presents an opportunity for early detection of sepsis, which can 
potentially make great strides in minimizing damage to patients.  
 A variety of algorithmic methods have been proposed by researchers, and 
research so far has been promising. Algorithms inretrospective studies have performed 
equal or better to standard protocols such as SIRS or SOFA. Some promising research 
even presents the opportunity to approach sepsis diagnosis and treatment in an entirely 
new manner. At the present stage, however, the field is at too early a stage for use in a 
clinical environment. This review intends to review some prominent types of machine 
learning algorithms, as well as discuss current concerns regarding machine learning-
based detection support systems (ML-DSS).  
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INTRODUCTION 
 
 Sepsis is a prevalent concern in critical care scenarios, and a leading cause of 
mortality for hospitalized patients. Tromp et al. estimates that 2% of all hospitalized 
patients are diagnosed with severe sepsis or septic shock.1,2 Later stages of sepsis have 
high morbidity, and early detection is very important for chances of good outcome. While 
specific definitions of sepsis are controversial, the mechanism of sepsis occurs from 
infection. A pathogen infects the bloodstream, triggering a systemic inflammatory 
response. If the response is large enough to become dysregulated, that can lead to organ 
failure in patients3. Upon onset of sepsis in an in-hospital setting, there is a 20-30% rate 
of mortality. Patients that survive to discharge often have increased risk for death in the 
following months and years, and can endure mood disorders and impaired physical or 
neurocognitive functioning4.  
 Unfortunately, sepsis detection is a complicated process. There is still no single 
unifying biomarker that clearly demarcates sepsis5 – rather, an evolving set of criteria, 
combining biomarkers and physiological symptoms, is used to diagnose the condition as 
rapidly as possible to allow for speedy administration of treatment. Some of these criteria 
look for consequences of organ damage brought about by inflammation and ischemia6, 
while others are assessments of visible symptoms such as changes in body temperature or 
respiratory rate. An example of this set of criteria is the Sepsis-III definition, which takes  
a series of physiologic parameters (heart rate, respiratory rate, etc.) and plugs them into 
an equation, a high enough score indicating a sepsis condition7. 
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 Making sepsis diagnosis more complicated is the high human resource 
requirement – A clinician has to take a series of vital signs, and using these values, 
calculate a ‘score’ for whether the patient shows symptoms of sepsis. Due to the 
complexity of the clinical setting, this can be a strain on already strained resources. Given 
this condition, there has been an interest in using computer technology as a diagnostic 
aid. There have been successful attempts to automatically sense when vital signs 
correspond to the guidelines of a protocol like Sepsis-III, but there is a limit to this 
usefulness – these systems will only alert at the “sicker stages” of onset of sepsis, rather 
than when a patient is in the early stages.  
 Sepsis has a high mortality rate, but even sepsis survivors face additional 
morbidity. Re-hospitalization occurs within a year for the majority of survivors,8 and for 
patients with sepsis and organ dysfunction, there is a 74% chance of mortality within 5 
years9. While having a computer process alert clinicians of sepsis is useful (as it could 
potentially decrease sepsis severity and therefore lower mortality rates), it would be more 
ideal to have a system that could predict sepsis before it presents in the patient, to prevent 
major organ damage and further increase patient morbidity. 
 With the recent rise in machine learning, there has been an interest in applying 
advanced algorithms to create a Machine Learning-Based Diagnostic Support System 
(ML-DSS) from biomarkers and readily-available Electronic Health Record (EHR) 
recordings. In theory, a properly trained algorithm could give a confidence level of how 
likely it is that the patient is becoming septic, before manual scores would even show a 
sepsis diagnosis. A few promising retrospective studies have been conducted, as well as 
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some live clinical studies. While the initial results are promising, more research should be 
conducted before machine learning algorithms are robust enough – and integrated into 
clinician workflow well enough – to be regularly used in an Emergency Department or 
Intensive Care Unit.  
 The purpose of this thesis is for clinicians with minimal computer programming 
knowledge, and computer science professionals with minimal clinical experience. It is 
intended to be a primer on the current state of sepsis, diagnosis and treatment paradigms 
for sepsis, an introduction to machine learning algorithms, and an exploration of issues 
related to machine learning implementation. 
 One important limitation of note is that definitions for sepsis recently 
changed in 2016, and as such, academic literature may not be comparable when 
discussing the same subject. Even literature after 2016 may refer to the older SIRS-based 
definition of sepsis. Until 2016, Sepsis was defined as a pathogenic infection in the 
bloodstream, combined with the host response (SIRS)10. In 2016, the condition was 
redefined as a “life-threatening organ dysfunction caused by a dysregulated host response 
to infection.”7 In both definitions, the presence of a pathogen in the blood causes an 
immune response, and since the bloodstream allows for fast movement throughought the 
body, the potential for pathogen damage (and immune response) becomes pervasive 
throughout the body. Prior to 2016, the presence of organ dysfunction was considered 
‘severe sepsis’, and where possible, this article uses the definition of ‘severe sepsis’ to 
minimize confusion.  
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SEPSIS MECHANISMS 
While the complete mechanisms for symptoms of sepsis are not fully understood, 
part of the mechanism is a bodily response that causes low oxygen perfusion to necessary 
tissues, which leads to impaired organ function11. Cytokine release at the presence of 
infection causes an immune response12, as well as an increase in coagulative response, as 
well as inhibition of fibrinolysis.13 This is normally intended to isolate a pathogen14 - if 
an infection is limited to a small, separated area, low oxygen perfusion works to induce 
cell death, which starves the infection of a nutrient supply. If this system is enacted 
throughout the body, however, the effect is not pathogen isolation, but potentially 
widespread damage. If not treated, this can lead to organ failure, and the onset of septic 
shock, which is defined as low blood pressure brought on by sepsis15.  
Since the underlying mechanism for sepsis is an infection in the bloodstream, the 
gold standard for sepsis diagnosis remains the presence of identifiable bacteria in the 
bloodstream16. However, pathogens only present in blood cultures only about 30% of the 
time17, so looking for proof of infection can be inconclusive. One issue of complexity is 
that there are multiple pathways that can lead to sepsis – for some patients there is an 
immune-mediated response, whereas in others there may be an immune suppression or an 
accelerated lymphatic apoptosis15. As such, sepsis can have a variety of symptoms and 
markers, but the absence or presence of a specific biomarker may not actually be 
indicative of sepsis. 
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ISSUES OF SEPSIS DIAGNOSIS AND TREATMENT 
There is a substantial increase in mortality from sepsis if the patient is diagnosed with 
sepsis while in a hospital setting. If sepsis patients are separated by whether they Present 
on Admission (POA) or are diagnosed while in the hospital setting (NPOA, or “Not 
Present on Admission”), the POA have about a 15% mortality rate, while NPOA patients 
have a significantly higher mortality rate of about 35%18. To some extent, this is because 
sepsis is difficult to diagnose – SIRS may be a symptom of an impending myocardial 
infarction rather than a bloodstream infection, which would require different 
treatments.18  
For rapid diagnosis, clinicians will often calculate a score, either the Systemic 
Inflammatory Response Syndrome (SIRS)19 score or the Quick Systemic Organ Failure 
Assessment (qSOFA)7 score. Manual paper-based aids are sometimes used for nurses to 
calculate a diagnostic SIRS or SOFA score, which can be time-intensive. An example is 
shown as figure 1.20  
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Figure 1. Example of an algorithmic guideline for nurses in Tedesco, et al. Nurses were encouraged to fill out the 
tool by hand, as a way to assess the severity of sepsis in a patient. 
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Human error and logistical difficulty add to the issues of sepsis treatment. The 
Surviving Sepsis Campaign recommends a series of four steps to be completed within 3 
hours of admission of a patient with severe sepsis: “(1) measure the serum lactate level, 
(2) obtain blood cultures before antibiotic initiation, (3) administer broadspectrum 
antibiotics, and (4) infuse 30 mL/kg of an intravenous (IV) crystalloid solution in patients 
with hypotension or a lactate level of 4 mmol/L or greater” (Bruce et al)21. Steps that 
require multidisciplinary coordination (such as antibiotic and fluid administration) are 
often not performed in that timeframe – and since one of the most important factors for 
prognosis is timely treatment, any delays can increase mortality rates. In a study of 
interprofessional coordination with regards to sepsis treatment administration, when 
compliance with the three-hour window improved, mortality from sepsis decreased 
significantly, even in a time of increased sepsis diagnosis.20 
 
BIOMARKERS AS A TOOL OF DIAGNOSIS 
To complicate matters, many of the symptoms of sepsis can present in other 
conditions such as pancreatitis22. Early signs of sepsis include symptoms such as fever 
and tachycardia, which, while indicative of sepsis, are also indicative of other non-
infection-based systemic inflammatory response syndromes.23 Symptoms could also be 
indicative of infections that have not gotten into the bloodstream - In one study, 
automated screening tools were implemented to flag any patients that met criteria for 
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SIRS. When the results were analyzed, only 44% of the patients ended up having sepsis, 
though a large percentage of the non-sepsis conditions were some sort of infection.24 
Since it is important to confirm the presence of pathogens, laboratory biomarkers 
are often used for diagnosis. 178 biomarkers have been proposed for sepsis diagnosis25, 
though it is important to note that no single biomarker exists that is specific only to 
sepsis. One reason so many biomarkers have been proposed is that sepsis has a complex 
pathophysiology – in addition to inflammation, coagulation, complement system 
activation and apoptosis are all part of sepsis pathophysiology, so markers have been 
proposed related to these, and other, steps in the process.25  
A few promising biomarkers stand out – Procalcitonin, Hyperlactatemia, and C-
Reactive Protein. Some of these biomarkers stand out for their specificity and sensitivity, 
while others do so because of their availability in the hospital setting. 
Procalcitonin23 has been proposed as a good potential biomarker, though its 
presence alone cannot indicate sepsis. Procalcitonin is virtually undetectable in healthy 
individuals, but as it is a prohormone for calcitonin, which is released as a response to 
bacterial infection, Procalcitonin levels can be used to measure bacterial infection.26 
Procalcitonin, is not highly specific or highly sensitive to sepsis25 (increased levels are 
present in other inflammatory responses such as trauma27 and major surgery28), but 
procalcitonin nevertheless has seen extensive use as a diagnostic tool.  
CRP is primarily produced by hepatocytes as a response to IL-6,29 but in 
comparison to an IL-6 laboratory test, CRP is more readily available. The presence of 
CRP is correlated with organ failure, to the point that persistently high levels of CRP 
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correlate with poor prognosis.30 However, CRP is also not specific to sepsis, and is 
increased in other inflammatory diseases.10 
Hyperlactatemia6 is another promising biomarker – lack of oxygenation causes 
tissues to produce lactic acid as a byproduct of anaerobic metabolism, so high levels of 
lactic acid can be monitored to monitor for the effects of SIRS. 
 In the case of neonates, cytokines and cell-surface molecules tend to be over-
expressed, so diagnostic tools sensitive to these signals provide a promising option for 
neonatal sepsis diagnosis16. Two markers that are promising for neonates are IL-12, and 
Interferon-produced Protein 10 (IP-10).25  
In a review of biomarker literature, Pierrakos et al. suggest that perhaps 
biomarkers are more effective for ruling out sepsis, rather than for diagnosing.25 
Specifically, PCT has a high negative predictive value for sepsis – that is, if levels of 
PCT are not high, it is unlikely that the patient has sepsis.31 
Other markers, arising from various effects of sepsis, are presented in Table 1. For 
a more complete picture, Pierrakos, et al., in their review of biomarkers, present a series 
of more than 170 biomarkers, categorized based on aspects of sepsis they are designed to 
monitor.25 
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Table 1. Markers used to differentiate sepsis, along with limitations. From Bloos, Reinhart et al10. 
 
COSTS OF SEPSIS TO PUBLIC HEALTH 
In 2013, Sepsis represented the most expensive condition treated in the United 
States.32 At roughly 23.7 billion dollars, it represented more than 6% of the total costs of 
all hospitalizations. A large part of the cost stems from re-hospitalizations – in the state of 
California alone, between 2009 and 2011, re-hospitalization due to sepsis represented a 
$500 million cost annually, more than the re-hospitalization costs of acute myocardial 
infarction and congestive heart failure combined.33  
Survivors of sepsis suffer additional morbidities. There is a five-fold increase in 
5-year mortality for survivors of an index sepsis episode.34 60% of sepsis survivors are 
 11 
re-hospitalized within a year, most often due to infection. Of those that are re-
hospitalized, there is a 17% mortality rate.8 For infection-related rehospitalizations, more 
than half of the cases were reported to be due to an unresolved or recurrent infection 
relating to the index sepsis event.35  
Costs for both index sepsis cases and re-hospitalizations are high. In a 
retrospective analysis of costs between 1995 and 1998, the average cost of an index 
hospitalization for sepsis with organ dysfunction was about $27,000, with patients 
requiring an ICU visit averaging about $36,00036. (It is important to note that costs are 
highly variable. The standard deviation for a mean of $27,000 was $55,000, reflecting the 
variable nature of individual costs depending on patient conditions such as co-
morbidities).  
For re-admissions, costs increased by another $11,000 to $25,000, depending on 
whether the patient survived past 12 months.36 A similar study conducted around 2011 
data showed a similar cost of $25,000 for hospital readmissions, with the most common 
(22%) cause of readmission being sepsis, though it was not clear whether this was due to 
a recurrent sepsis or new infection.37  
 
EVOLVING DEFINITIONS OF SEPSIS 
The definition of a clinical diagnosis of sepsis is not universally agreed upon. 
While the gold standard of Sepsis remains the proof of infection in the bloodstream, the 
clinical presentations of the condition are varied and can be different depending on 
factors such as age and compounding factors such as alcohol use disorder.  
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In 1991, SIRS was defined by Bone et al. 22 as a clinical standard to diagnose 
Sepsis. Sepsis was defined as SIRS with a suspicion or finding of blood infection, which 
came to be known as the “Sepsis-1” definition.  
SIRS is defined as a patient having two of the following four conditions: 
“tachycardia (heart rate >90 beats/min), tachypnea (respiratory rate >20 breaths/min), 
fever or hypothermia (temperature >38 or <36 °C), and leukocytosis, leukopenia, or 
bandemia (white blood cells >1,200/mm3, <4,000/mm3 or bandemia ≥10%)” (Marik et 
al)19. A diagnosis of sepsis requires proof or a suspicion of infection, as well. There are 
three states of sepsis within Sepsis-I – ‘sepsis’, ‘severe sepsis’ (organ dysfunction 
brought upon by sepsis), and ‘septic shock’ (low blood pressure brought on by sepsis).  
One of the advantages of Sepsis-1 was that its diagnosis required largely external 
criteria – heart rate, respiratory rate, and temperature can all be readily assessed via a 
machine or clinician observation, leaving only white blood cell count (WBC) as a test 
that required laboratory examination. However, this was not without consequence - while 
SIRS became widely standardized for the diagnosis and treatment of sepsis, it has been 
criticized for a low specificity.38 Non-sepsis conditions such as ischemia, tissue injury, 
and pancreatitis can present with SIRS, 22 and since the recommended treatment for each 
condition is not the administration of antibiotics, there was concern of potential 
misdiagnosis and treatment that does not improve the patient’s condition. In addition, in 
one study, 13% of patients presented as negative for SIRS, yet still had sepsis.39  
In 2016, an attempt to address this issue of low specificity was made by the 
Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care 
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Medicine (ESICM). The new definition, known as Sepsis-III, largely abandons SIRS as a 
criteria19. Sepsis-III redefines sepsis as “life-threatening organ dysfunction caused by 
dysregulated host response to infection”7. Before this definition, ‘Sepsis’ was defined as 
the presence of bloodstream infection and SIRS, while the presence of organ dysfunction 
was considered ‘severe sepsis’. With the new Sepsis-III definition, ‘severe sepsis’ has 
largely become renamed to ‘sepsis’, and infection without organ dysfunction is 
sometimes referred to as ‘pre-sepsis.’40  
In re-casting sepsis as a condition of organ dysfunction (as opposed to 
inflammatory response), SIRS detection was replaced with criteria for the detection and 
diagnosis of organ dysfunction. The proposed measure was the Sequential Organ Failure 
Assessment (SOFA) score, an assessment found to be more predictive for in-hospital 
mortality than the SIRS criteria. SOFA looks at six major categories, rather than four, and 
assigns point values from 0 to 4. Higher scores indicate higher mortality rates, and the 
direction of change in SOFA points indicates the direction of patient prognosis. In other 
words, if the SOFA score increases, the patient is going into a worse condition. Increases 
in SOFA score of more than 2 points to potential organ dysfunction.41 A table of the 
SOFA scoring sheet and score analysis is presented in Table 2. 
 Note that the SOFA score uses multiple laboratory tests (Platelet, Bilirubin 
concentration) and also a measure of mental consciousness impairment (Glasgow Coma 
Score)42. It also monitors multiple organ systems. A simpler analysis, the quick 
Sequential Organ Failure Assessment (qSOFA) presents a faster alternative, designed for 
rapid diagnosis within an intensive care unit. The qSOFA uses only three measures – low 
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blood pressure ( low blood pressure (SBP≤100 mmHg), high respiratory rate (≥22 breaths 
per min), or altered mentation (Glasgow coma scale<15).43 Each of these measures are 
accessible without bloodwork, allowing for a relatively rapid analysis which can then be 
followed up with a more comprehensive SOFA analysis if needed.    
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Table 2. SOFA score categories and criteria. Note that increased score 
trends indicate significant chances of mortality. Table from Chamberlain, 
NR36  
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While the new Sepsis-III definition has generally been accepted in the hospital 
setting, it is not without criticism. One criticism stems from the loss of a definition for 
bloodborne infection without organ damage. Before Sepsis-III, any infection and 
dysregulated immune response would be considered sepsis, regardless of organ 
dysfunction. The change in definition has been seen as potentially precluding treatment 
for the early stages of infection40, which could allow for better patient outcomes. In at 
least one study, qSOFA was found to be poorly sensitive for organ dysfunction,44 and 
argued that the SIRS score conveys “more prognostic and clinical information”,44 even if 
SOFA presents a comparable analysis of mortality rates. Consensus has not been reached 
on the preference of SIRS or SOFA/qSOFA. 
 
TREATMENT OF SEPSIS 
For proper treatment of sepsis, early detection is critical. The longer a pathogen is 
in a bloodstream, the stronger the immune response will be, and the stronger symptoms 
such as organ dysfunction will be. As organ dysfunction increases, the chance for 
secondary complications increases, and mortality rates increase. At some point, 
conditions become bad enough to cause low blood pressure, known as septic shock. Once 
a patient has septic shock, every hour delay increases the chance of mortality by 8%.45  
Once a diagnosis of sepsis, severe sepsis, or septic shock is made, treatment 
options focus on detecting the source of the infection, minimizing damage to the body, 
and eliminating pathogens. Guidelines have been established by the Surviving Sepsis 
Campaign which recommend a series of procedures.11 Since there is likely a bacteria 
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causing sepsis, the first step is to understand what bacteria that is, so two blood cultures 
are taken, aerobic and anaerobic. Identifying the bacteria allows for more targeted 
administration of antibiotics, and pathogens tend to depend on the original infection 
site.46 For instance, Staphylococcus aureus and coagulase negative staphylococci are the 
most causative organisms for meningitis and pneumonia46, and Escherichia coli is the 
most prevalent cause of urinary tract infection-related sepsis.47  
This, however, should only be done if it does not interfere with administration of 
antibiotics within an hour of diagnosis – if it does, the antibiotics take precedence.11 The 
antibiotics should be broad spectrum at this point, or an antibiotic that works on both 
gram-positive and gram-negative bacteria. Considering the presence of drug resistant 
bacteria, some possible supplemental drug administration must be considered. For 
instance, if there is a risk of MRSA in the area, drugs such as vancomycin or teicoplanin 
are suggested supplements.11    
Next, if the patient has hypoperfusion, the Surviving Sepsis campaign guidelines 
suggest administration of IV crystalline fluid, 30 ml/kg, within 3 hours. Finally, a lactate 
assessment should be regularly done, and the goal should be to normalize lactate levels, 
which implies proper tissue perfusion.11  
 
COMPUTER-BASED DETECTION SYSTEMS 
As early detection and treatment of sepsis dramatically affects prognosis48, there 
has been an interest using computational systems to monitor patients without the need for 
a clinician. In theory, a computer system could actively monitor a patient’s vital signs for 
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symptoms characteristic of early sepsis, and raise a warning to clinicians if the right 
criteria is met. At the most basic level, this would amount to a computer reading vital 
signs and laboratory data, tabulating a score based on Sepsis-3 or APACHE criteria, and 
alerting a clinician if the basic requirements for sepsis are met.  
An example of this was conducted at Barnes-Jewish hospital in St. Louis49. Using 
an automated warning tool that required manual nurse entry of hemodynamic data and 
automated entry of laboratory data, the tool would generate and send an alert to staff if a 
patient registered as a potential case. All patients that registered an alert went on to have 
sepsis, severe sepsis, or septic shock within 48 hours of an alert being generated, and the 
early warning was reported to significantly increase the rate of interventions within 12 
hours of a generated alert49.  
While this system is functional, it is limited to being, essentially, another sensor. 
It lacks the ability to predict worsening conditions, and will only alert clinicians at 
conditions that meet sepsis criteria, rather than when the patient is deteriorating into 
sepsis. At that point, there may already be damage to the body. Yet, detecting sepsis 
before it shows the established symptom criteria is tricky even for a clinician – 
Myocardial Infarctions, for instance, can sometimes also cause SIRS symptoms, so 
simply alerting clinicians every time SIRS is detected would not be an effective 
preventative measure. Simply setting notices for potential SIRS criteria could lead to alert 
fatigue, potentially neutralizing the benefits of an automated sepsis detection system.   
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MACHINE LEARNING : A PREDICTIVE, RATHER THAN REACTIVE, TOOL 
As such, for a system to effectively alert clinicians to potential Sepsis situations, 
computer programs have to move past the idea of simply programming a checklist of 
symptoms, and move into smarter, Machine-Learning-based predictions.  
Machine Learning is a broad umbrella term encompassing a variety of algorithmic 
approaches to combing data to make predictions. Broadly, machine learning takes a large 
set of data and uses statistical analysis to “learn” patterns in the data. Large volumes of 
data that are difficult for a clinician to assess and quickly analyze can be processed at 
significantly higher speeds by algorithmic analysis. For instance, patients in a critical-
care units can be continuously monitored for heart rate and respiratory rate, and these 
data points can be analyzed for trends without human assistance. When combining this 
with electronic medical records, laboratory analysis of biomarkers or white blood cell 
(WBC) count, a machine learning algorithm has a potentially rich field of data to use in 
order to detect patterns in patients with sepsis. The specific diagnosis of sepsis requires 
some indication that the SIRS is infection-related, so the addition of biomarkers aid in 
telling a clinician that sepsis-specific treatments (as opposed to, say, cardiac arrest) are 
called for.  
Machine Learning has recently seen a renaissance in the fields of statistics and 
computer science, and has since been applied to fields as separate as melanoma detection 
and language translation. The origins of what is currently called “machine learning” are 
rooted in statistical analysis, and trace back more than 30 years50. However, recent 
increases in both the volume of accessible data (including EHR data) and cheap 
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computational ability have allowed for a substantial increase in activity in the field.51 In 
an abstract sense, machine learning represents a shift in program design – instead of 
programming a set of rules, the program designer creates an algorithm that can take an 
“unknown” value, use statistics to make ‘guesses’ about what that value means, and then 
check that ‘guess’ against the right answer. The system does not necessarily have a 
reference for what a specific value or condition means – it simply recognizes that certain 
values are statistically correlated with certain outcomes, and uses that analysis to make a 
prediction about newly presented information.  
There are multiple styles within the study of machine learning, ranging from the 
relatively simple “logistic regression” to the very complex “deep learning”. It is 
important to understand, however, that “more complex” doesn’t necessarily mean 
“better” - in general, the more complex the machine learning algorithm, the more 
powerful the algorithm or the more data it can process, but the more difficult 
development and optimization becomes. 
 
SEPSIS PREDICTION WITH MACHINE LEARNING 
A number of machine learning experiments pertaining to sepsis prediction have 
been attempted. The studies range in algorithmic styles, from Deep Learning to Hidden 
Markov Models to more basic logistic regression. Almost all studies are retrospective 
analyses of EHR datasets, many from MIMIC-II and MIMIC-III. Retrospective analysis 
projects are interested in predicting sepsis that is occurring to a patient while in a hospital 
setting, so often they will remove data about patients entering with a diagnosis of sepsis, 
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or that is diagnosed with sepsis within a few hours of arrival.52 Not all studies are 
retrospective – Algorithmic development company Dascena created a commercial 
product, InSight, as an ML-DSS tool, and performed a randomized clinical trial. The trial 
saw a 12.4% decrease in mortality when using Insight.53  
The specific biomarkers and vital signs collected varies for each study. Shamim et 
al. used 65 different variables, ranging from blood pressure to fibrinogen, to the standard 
deviation of respiratory rate intervals52. Taneja et al. used six biomarkers, and found that 
specific biomarkers would be of peak importance at different stages of sepsis (for 
instance, nCD64 was more indicative of early sepsis, while high PCT levels were more 
indicative of latter stages of sepsis).54 This was used to great effect for that study, as the 
algorithm could accurately suggest the severity of sepsis that the patient was in.   
Interestingly, one of the first published studies was a prospective trial. In 2010, 
Tang et al separated patients coming into the Emergency Department with sepsis 
symptoms as either SIRS or Severe Sepsis. 28 total patients began, and 2 were excluded 
due to complications. It found that the algorithm was able to successfully classify SIRS 
versus severe sepsis, though they found issues with specificity.55 They suggested a larger 
sample size and more comprehensive cardiovascular features as possible improvements 
for later studies.  
In 2011, Ohno-Machado, editor of the Journal of the American Medical 
Informatics Association, called for an investigation into Natural Language Processing 
(NLP) for EHRs, noting that the unstructured handwritten notes provided in EHRs 
contain important information to use in research.56 That same year, Sawyer et al. 
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published a report of a computerized non-machine learning alert system, which was 
based on “shock index (heart rate divided by systolic blood pressure), MAP, international 
normalized ratio, WBC count, hemoglobin, absolute neutrophil count, serum albumin, 
total bilirubin, and sodium.49 The prospective clinical trial showed increased speed of 
intervention, antibiotic escalation, intravenous fluid administration, and oxygen therapy. 
It noted no change in hospital mortality or length of stay, however.49 
Convertino et al. published a study of machine learning for diagnosing 
hemorragic shock, for both civilian and battlefield trauma. The study used lower body 
negative pressure as a model of hemorrhage until hemodynamic decompensation. The 
study was “96.5% effective in predicting the estimated amount of reduced central blood 
volume”.57 While not directly applicable to septic shock, the study does have some 
similarity and promising findings.   
In 2014, Gultepe at al. focused on hyperlactatemia as a measure of potential septic 
mortality, using machine learning as a prediction tool. A retrospective study of 741 
patients from the University of Southern California Davis were used, and their vital signs 
and white blood cell (WBC) counts were associated with sepsis occurrence and mortality. 
The intent was to use the algorithm to predict lactate level and mortality risk. Using only 
vital signs and WBC count, they were able to make predictions of lactate level with an 
accuracy of 0.99, and using mean arterial pressure, median absolute deviation of 
respiratory rate, and median lactate levels, they were able to predict mortality to an 
accuracy of 0.73 retrospectively.58  
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That same year, Mani et al. looked at neonatal sepsis diagnosis with machine 
learning, comparing nine ML algorithms to clinician diagnosis. The retrospective study 
looked at 299 neonatal patients from an 18 month period from January 2006. The study 
generated temporal variables from time-stamped measurements from the laboratory, in 
order to give a time-sensitivity to the processed information. Interestingly, the study 
looked at both culture-positive and culture-negative sepsis, as bacterial cultures don’t 
always present a pathogen in cases of sepsis.17 The results were significant – when 
including culture-negative sepsis, “the treatment sensitivity of all the nine ML algorithms 
and specificity of eight out of the nine ML algorithms tested exceeded that of the 
physician…When culture-negative sepsis was excluded both sensitivity and specificity 
exceeded that of the physician for all the ML algorithms. The top three predictive 
variables were the hematocrit or packed cell volume, chorioamnionitis and respiratory 
rate.”59 
Nguyen et al. published another study of a non-ML alert automated alert system, 
based on SIRS, in 2014. In the 795 automated sepsis alerts that were generated, there was 
a 44.7% prevalence of sepsis. In 300 randomly selected non-sepsis alerts, there was a 0% 
prevalence of sepsis. While a step in the right direction, the low accuracy suggests that a 
more complex algorithm for prediction was necessary.  
Tsoukalas et al. (2015) noted the difficulty of making a framework for clinical 
decision support when data was incomplete, as in EHR records. Nevertheless, they used a 
larger dataset of 1492 patients, and used a form of the Markov Model (explained below) 
to derive an optimal policy for treatment. When that optimal policy was followed, there 
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was an increase in transition to better states (25.9% vs. 12.9%) and a decrease of 
transition to worse states (33.7% vs. 51.2%).60  
In 2016, Dascena, a diagnostic algorithm company specializing in ML-DSS for 
sepsis, published a pair of papers on their tool, InSight. These were retrospective analyses 
of patients in the MIMIC-II61 and MIMIC-III62 databases. In the MIMIC-II study, the 
focus was on hospital-acquired sepsis, so the company screened for patients that do not 
present with SIRS at the time of admission or within the first four hours of stay, and who 
had documented measurements for SBP, pulse pressure, heart rate, temperature, 
respiration rate, WBC, pH, Blood oxygen saturation and age (a total of 1,394 patients). 
Of that set, patients whose record contained an ICD9 code (995.9) for sepsis and met the 
SIRS criteria for a 5-hour period of time were used for the trial, a total of 159 patients. In 
that case, InSight was able to predict the possibility of a patient being given an ICD code 
and presenting with SIRS criteria 3 hours before the ‘zero hour’ (point of first diagnosis), 
to an accuracy of .92, higher than a PCT test (which had an accuracy of 0.85).61 While 
promising, the sample size of 159 is somewhat inconclusive, which might suggest why 
the second study, based on MIMIC-III was used.  
The MIMIC-III study analysed a set of 1,840 septic ICU stays, against 17,214 
nonseptic patients. Interestingly, this assessment also tested the system “in the presence 
of data sparsity” – that is, when randomly selected pieces of information were deleted 
from the EHR data. Insight was also tested against a series of diagnostic criteria, such as 
SIRS, SOFA, MEWS (Modified Early Warning Score) and SAPS II (Simplified Acute 
Physiology Score II). For markers, InSight used systolic blood pressure, pulse pressure, 
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heart rate, respiration rate, temperature, Glasgow Coma score, and peripheral capillary 
oxygen saturation, arguing that “all of these features are nearly universally available at 
the bedside and do not rely on laboratory tests.” The study found a higher performance 
than SAPS II and SOFA, and comparable performance with other machine learning 
algorithms, without requiring biomarkers.  
While this information is promising, it is important to note that it is retrospective, 
and not directly used in a clinical trial. Dascena was later used in a prospective 
randomized clinical trial, in a paper published by Shimabukuro et al53. The intent was to 
measure if the use of Dascena’s machine learning algorithm would reduce length of stay 
and mortality rate in the hospital. Similar to the MIMIC-III study, the algorithm was 
compared to SIRS, SOFA, qSOFA, and MEWS systems. In this case, however, in 
addition to the non-laboratory variables (blood pressure, respiratory rate, etc.) used in the 
preview test, labs such as pH, WBC count, and glucose were included. The system would 
then generate a risk score for severe sepsis between 1 and 100, and if the patient 
exceeded a score of 80, the charge nurse was notified. The sample size was again small at 
142 patients, but there was a sizeable 20.6% reduction in length of stay, and had a 12.4% 
drop in mortality as well. Patients in the experimental (ML-aided) group also received 
antibiotic treatment an average of 2.76 hours earlier.53 
Taylor et al (2016) presented a machine learning algorithm that used 20 variables, 
from oxygen saturation to blood urea nitrate (BUN), to make its predictions. It similarly 
found higher accuracy than the SIRS definition.63 Goodman et al (2016) looked 
specifically at using machine learning to make timely predictions of extended-spectrum 
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β-lactamase (ESBL)-producing bacteria.64 Since ESBL bacteria can hydrolyze most 
broad-spectrum β-lactam antibiotics65, many antibiotic regimens have limited activity 
against ESBL producers66, and awareness can help clinicians use the right antibiotics. 
Interestingly, the study used a form of machine learning called ‘recursive partitioning’ 
that produces a more user-friendly, interpretable decision tree, so that clinicians can read 
its logic more easily.64 The study used five predictors: “history of ESBL 
colonization/infection, chronic indwelling vascular hardware, age ≥43 years, recent 
hospitalization in an ESBL high-burden region, and ≥6 days of antibiotic exposure in the 
prior 6 months.” The finding had positive and negative predictive values above 90% 
using those predictors. 64 
A few studies have focused on improving algorithm design or streamlining 
workflow. Ghosh et al. used Hidden Markov Models (HMM) to create an analysis, 
attmepting to create time-to-event prediction models, that see the path to sepsis as a timed 
series of patterns.67 The study only used MAP, heart rate and respiratory rate, and used 
that to predict, given a patient at a certain state, how likely it was that the patient was 
going to move towards a condition of septic shock. The study argues that the use of timed 
relational metadata about the three variables has an improved effect on prediction.67 Hu et 
al. focused on proposing a more automated model for manual chart review, using 
machine learning to ‘read’ outcomes and look for post-operative complications such as 
sepsis.68 The paper explored a few machine learning styles, suggesting ideas for future 
research.  
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Horng et al (2017) focused on using free text (such as clinician’s notes in an 
EHR) to augment the machine learning algorithm. This retrospective study processed the 
free text and would then add information such as vital signs and demographic 
information to the algorithm. They found that adding this free text information improved 
discriminatory ability, as the area under the curve (AUC) increased from 0.67 to 0.86.69 
Taneja et al (2017)54 presented a study that granularized phases of sepsis, and 
looked to find the presence of biomarkers for specific stages. They combined the study of 
16 non-traditional biomarkers with 15 EHR variables, to find patterns. The study argues 
that a “one size fits all” system for every potential sepsis patient is an incomplete picture 
– providing a range of biomarkers and vital sign information would allow an algorithm to 
more accurately pinpoint the stage of sepsis and suggest personalized treatment.54 
Kam et al (2017) is one of the first papers to introduce the concept of deep 
learning into sepsis prediction. The paper presented a response to InSight, using deep 
feedforward networks to create an algorithm and compare it to InSight. The study used 
the same MIMIC-II database as one of InSight’s studies, and leveraged the more complex 
‘long short-term memory’ ability to create an algorithm that can learn sequential patterns 
and make conclusions from them (this is further explained below in ‘Deep Learning’).70  
Cockrell et al. (2017)71 and Peterson et al. (2018)72 presented two related papers 
that paired deep learning with simulation. Cockrell et al. proposed a simplified sepsis 
computer simulation, which could simulate up to 7 million sepsis ‘patients’ by creating a 
virtual immune system response. Peterson et al. took that simulation system and applied a 
deep learning algorithm to it, and enabled reinforcement learning – that is, it allowed the 
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algorithm to take ‘actions’ on the virtual patients, and learn how effective its actions were 
to reduce symptoms. This led to an algorithm that would analyze the patterns of specific 
cytokines in patients, and would suggest a multi-cytokine mediation therapy, 
personalized to the patient.72 While this needs to be validated with studies on live 
organisms, the study shows great promise, and is a far cry from the “one size fits all” 
nature of diagnostic protocols like SIRS and SOFA.  
Raghu et al (2017) applied deep reinforcement learning to a retrospective analysis 
of the MIMIC-III database. The study then used the reinforcement “action” system to 
allow the algorithm to make various protocols for when to administer IV fluids and 
vasopressors, specifically. It would then look at the outcomes of the various patients, and 
adjust its protocols to maximize the number of successful outcomes. The study found that 
doctors that followed the algorithm’s timing protocols for administering vasopressors and 
IV fluids ended up with the least mortalities.73  
A GROWING TREND OF ROBUSTNESS 
The papers here show a gradual increase in complexity with regards to the 
application of machine learning in sepsis. At first, analysis resembles statistics more than 
complicated machine learning, and is used more to make conclusions about clinician 
behaviour. As the algorithms become more complex, a trend of retrospective analysis 
finding predictions of equal or higher accuracy than SIRS or SOFA emerges. Later 
research focuses on approaching sepsis at new angles – simulating and proposing new 
ways of looking at stages of the disease, and tailoring personalized treatments based on a 
network of biomarkers. While the applications of financial and logistical feasibility need 
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to be taken into account, this represents a new, exciting opportunity in sepsis diagnosis 
and treatment – instead of the confusing, unspecific, time-intensive nature of diagnostic 
tools such as SIRS and SOFA, machine learning could create highly specific treatments 
that can look at larger volumes of data than a clinician could, and suggest specific 
treatments designed for specific stages of sepsis.  
Of particular interest is the theorized multi-cytokine-based prediction system 
proposed by Peterson et al.72 Sepsis and SIRS have both been criticized for issues with 
specificity, and clinician diagnosis from visually identifiable symptoms combined with a 
handful of commonly available biomarkers is likely always going to present an 
incomplete picture compared to a granular analysis of cytokine activity in the body. It 
will be interesting to see if the future analysis of this proposal leads to a new mode of 
thinking regarding sepsis diagnosis.   
 
MACHINE LEARNING FUNDAMENTALS 
A comprehensive analysis of the multiple types of machine learning is beyond the 
scope of this paper, and it is important to note that there are dozens of types of machine 
learning algorithms that one can apply to a problem such as sepsis (LASSO, naïve Bayes, 
random forest) that are used in machine learning approaches to sepsis detection. 
However, It is useful for clinicians to have an understanding of the basics of machine 
learning, to understand what is and is not being analyzed.  
Machine learning represents a philosophical shift in the tackling of a problem. 
Instead of attempting to define every possible angle to a problem and code solutions for 
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each possibility, a machine learning program is designed to be given a set of data, and to 
find patterns through statistical analysis. The advantage here is that problems that cannot 
be simplified into a simple rule set can be tackled with machine learning. 
A classic example of this is the detection of handwritten numbers74. Standardized 
fonts will always show a ‘9’ with the same width, the same curve or line representing the 
lower half of the ‘9’, but handwritten versions can vary dramatically, and programming a 
ruleset to cover every possible combination would be very complex. Instead, if a machine 
learning program is given a database of handwritten numbers, along with a ‘correct 
answer’ for which number the drawing represents, it is possible to train the program to 
predict the numbers to a high degree of accuracy. The program is told only that there are 
10 values (0-9) and that the image it is presented with is one of those numbers. The 
computer makes a ‘guess’, then looks at the right answer (provided with the image). If it 
is incorrect, it modifies parts of its algorithm and tries again with the next number, until it 
is able to recognize numbers with a high accuracy75. 
This is, of course, an oversimplification, as there is a deep level of complexity 
surrounding many parts of machine learning. The actual structure of the algorithm, how it 
decides to make an actual guess, and how it corrects for a ‘wrong’ guess, are complicated 
topics with many avenues to explore. However, there are a few basic similarities worth 
delineating for a clinician to understand.  
Many machine learning algorithms use a node-based system (referred to as 
‘neurons’), where a decision in one neuron activates the next neuron, in a manner 
inspired by the neuron excitation system used in the human brain76. While the ultimate 
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design is not entirely the same as the human neuronal system, the basic structure is 
similar. To continue with the example of handwritten digit recognition, imagine that there 
are only 10 possible right answers (0-9), and the algorithm is designed to conclude which 
of the 10 answers it is “seeing” in the image of a black ‘3’. In order to do so, it constructs 
a series of columns, each with a number of neurons. The final column consists of 10 
neurons, the answers 0-9. It then looks at the information provided by the image (for 
instance, the black/white value of pixel 1, pixel 2, pixel 3, etc). Pixels are then grouped 
into neurons, and the neurons that contain black color will then ‘fire’ and turn on other 
neurons, similar to an organic neuron system. Eventually, the neurons all must settle on 
one of 10 possible answers, 0-9, by looking at which groups of neurons are being turned 
on. 
However, not every piece of information will be equally relevant – for instance, 
the presence of hyperlactatemia is an more relavant indicator of sepsis than age or body 
weight, so that information must be seen as more significantly by the program. In the 
case of recognizing numbers from an image, perhaps corners of an image are less likely 
to be relevant for understanding the image than the middle area. As such, the computer 
must learn to ‘weight’ some information over others. This weighing of certain neuronss 
becomes key to the machine’s “learning”. Initially, all neurons might be weighed 
randomly, or equally. As the program gets more things wrong or right, it adjusts the 
values of these weights, and with enough repeated cycles, it finds that certain weights are 
more likely to produce a right answer than others. This works in a manner similar to the 
psychological principal of positive and negative reinforcement – the more a weight 
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supports correct answers, the larger it becomes. In the end, through hundreds to 
thousands of guesses and tiny corrections, the weights are tuned to reliably ‘read’ what 
the machine is being given.  
 
LIMITATIONS TO MACHINE LEARNING 
Due to the nature of this style of learning, there are a few strong caveats. For 
instance, machine learning systems are very ‘data-hungry’ – that is, they require large 
sets of data before they can start doing accurate predictions. For instance, the MNIST 
database of handwritten digits contains 60,000 ‘training’ samples (for the machine 
learning algorithm to train on) and 10,000 ‘test’ samples for the algorithm to attempt 
prediction with77. The amount of examples necessary to properly train a specific 
algorithm differs for the various types of machine learning algorithms (Markov Models, 
Deep Learning, Logistic Regression, etc.). The high volume of examples, however, is in 
many ways a product of the statistical roots of machine learning, as large volumes of data 
are required to accurately assess trends in the data. As changes to the weights of 
algorithms are made incrementally, large volumes of examples are needed in order for the 
program to make predictions with a high degree of accuracy.  
Because of this high volume requirement, getting a large enough volume of data 
was previously a difficult task. However, the growing volume of electronic health records 
(EHR) has allowed for the automated collection of relevant data, which has allowed the 
regular use of machine learning for data analysis to be a viable, potentially powerful 
tool.78   
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Unfortunately, a second major roadblock impedes progress, even with an EHR – 
the problem of ‘dirty’ data. As the program does not necessarily know what a specific 
value means, it is largely unable to discern if a certain value is ‘correct’. In machine 
learning, the learning is only as good as the data presented to it – if the data collected is 
missing critical information, is mislabeled, or is riddled with incorrect information, the 
machine will make incorrect assumptions due to having this faulty data. For data 
scientists, cleaning data is a large, resource-intensive part of their job – enough so that it 
is considered the major roadblock to progress when working on a system79. ‘Clean’ data 
refers to data that has been checked for missing data, which can be a very time-intensive 
process.   
One of the issues that arises from the clinical data collected is that the quality and 
comprehensiveness of clinical data is at a lower level than research data.80 This is partly 
due to a difference in priorities when collecting data, as research-based data gathering 
will have a different set of priorities than clinical data gathering.81 Another issue is that 
clinical data will often have handwritten notes describing a physician’s diagnosis, and 
those notes are generally unstructured69 compared to standardized codes, and may contain 
shorthand abbreviations that are not standardized. If an important piece of information is 
contained in these notes, a machine learning algorithm would have to learn to take that 
into account. Some research has been done into natural language processing (NLP) for 
this purpose,56 and some studies have used this improve Machine Learning diagnosis for 
sepsis.69  
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ADVANCED MACHINE LEARNING ALGORITHMS – DEEP LEARNING, 
HIDDEN MARKOV MODELS 
In recent years, the challenges that machine learning have been able to address have 
gotten more and more complicated. For instance, image recognition algorithms have been 
programmed that can recognize skin based melanoma cancers with a dermatologist’s 
degree of accuracy, using only a phone’s camera82. Advancements in this vein have come 
about because of an increase in computing power, the commercialization of 
computational tools such as IBM Watson and because of further research into advanced 
forms of machine learning, such as Deep Learning.  
HIDDEN MARKOV MODELS 
 Advanced systems of machine learning are designed around different paradigms, 
and these differences allow for predictions in different veins. For example, one approach 
is the Hidden Markov Model, a variant of the Markov Model (or Markov Chain). Similar 
to traditional methods, Markov Models look at a limited series of states (for instance, 
‘healthy,’ ‘sepsis,’ ‘severe sepsis’, ‘septic shock,’ ‘deceased’), and calculates the 
probability in of moving to a new state depending only on the current state (a rule known 
as the “Markov Property”).67 The intent is to model the relationship between states as a 
function of probability. A common example, described in Ramage 200783, is the 
modelling of weather patterns. If the current state of weather in Los Angeles is “sunny”, 
what is the probability that it will transition within a few days to “cloudy,” or “raining?” 
If every transition is calculated (for instance, by recording weather states for 100 days 
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and noting transitions), a set of data can be generated that models the chance of a certain 
weather state, based on the current stated.  
 
Figure 2. Sample probability table of transitions between weather states. In this set of data, if the current state is 'sun', 
there is an 80% chance of the next day's weather being the same state of 'sun', and a 10% chance of changing to either 
'cloud 
A normal Markov Model requires that the states are observable – that is, one must be able 
to go outside and see the weather for 100 days, in order to create the table. This presents a 
difficulty, therefore, if one wished to calculate this same probability, but for weather in 
the past when no weather data was taken. Similarly, in the case of sepsis, the condition of 
blood infection is similarly hidden from the clinician –testing for the presence of 
pathogens in the blood of a septic patient yields a positive result only 30% of the time17 – 
so the clinician must assess the likelihood of the patient having sepsis based on other 
factors such as heart rate or respiratory rate or hyperlactatemia. In cases like this, the 
Hidden Markov Model is used.  
 In the Hidden Markov Model, one cannot observe the system they wish to model, 
and as such must model an ancillary, related system. In the analogy of weather, imagine 
if the modeler was attempting to model the weather in Los Angeles 10 years prior, and 
the weather data was not recorded during the required time period, but daily sales data of 
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umbrellas in a local open-air mall was readily accessible. Logically, sales data of 
umbrellas correlate to rainy days, though the conclusion is not necessarily guaranteed 
(perhaps on a dry day, someone needs to purchase an umbrella for a trip to another rainy 
city, or on a rainy day, fewer people purchase an umbrella because they bought one the 
rainy day before). While the information doesn’t correlate directly, one could create a 
model of various purchasing states, and then use that to make a model predicting weather 
patterns.  
  In the case of Sepsis, then, the use of observable factors (heart rate, respiratory 
rate, etc.) are available for a hospitalized patient, while the ‘state’ of sepsis is not readily 
accessible. Logically, however, the factors have a correlation to sepsis, as defined by 
systems such as SOPA and APACHE II guidelines. As such, the rates of transition from, 
say, ‘normal heart rate’ to ‘tachychardic heart rate’ are observable and modelable, and 
can be used to predict the ‘hidden’ system (the probability of going from ‘mildly septic’ 
to ‘severely septic’ given one’s current health data). 
Two studies have used the Hidden Markov Model system for sepsis prediction. 
Peterson, et. Al used the system to predict five states – discharged, sepsis of severity level 
1,2,3 (known as S1, S2, S3) and deceased – retrospectively on a collection of data from 
the Kaiser Permanente Northern California Data Set.84 The model was built using five 
common vital signs – respiratory rate, systolic blood pressure, diastolic blood pressure, 
heart rate, and temperature. To give context to that data, there were three “covariate” 
factors used as well – age, acute physiology score (LAPS2), and chronic disease burden 
score (COPS2). Using the records of 20,000 patient hospitalization episodes,84 the system 
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modeled a range of likely values for the five vital signs, for ‘discharged’, ‘S1’, ‘S2’, and 
so on.  This data was then validated against the “Sepsis-1” SIRS criteria and qSOFA, and 
used to predict mortality risk, which was identified as the S3 state. Using this 
retrospective data, the study found the Hidden Markov Model used to be more accurately 
predictive of high-risk sepsis states than the sepsis-1 or qSOFA criteria. 
Ghosh et al. extracted mean arterial pressure, heart rate and respiratory rate from 
the MIMIC-II database, and mapped their interactions to a Coupled Hidden Markov 
Model (CHMM). The study found that coupling these variables and creating a model of 
their influence on each other resulted in a statistically significant increase in prediction of 
septic shock compared to baseline models.67 
Gultepe et al. used Hidden Markov Modeling to predict lactate levels, and then 
used that system as part of a larger machine learning algorithm.58 Using only vital signs 
and WBC count, they were able to predict lactate levels to an accuracy of 0.99, and then 
couple that information with analysis of arterial pressure and respiratory rate to predict 
patient mortality in a larger machine learning algorithm. Vital signs and WBC were the 
‘known’ markov variables, and those were used to understand the ‘hidden’ relationship of 
lactate levels.  
DEEP LEARNING 
As mentioned before, one of the biggest impediments to machine learning is the necessity 
of clean, accurate data. The data has to also be as similar as possible, to limit the potential 
for the machine learning algorithm to make incorrect conclusions. For instance, in the 
example of handwritten number recognition, a traditional machine learning algorithm 
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would have a harder time being as accurate if the numbers were presented at dramatically 
different sizes, or in different colors. The computer might conclude that an important 
characteristic of a ‘4’ is the color red, while a ‘5’ is twice the size of a ‘4’. Another 
famous example comes from image recognition – a ‘standardized’ set of faces would 
need to be of similar skin tone, with similar lighting condition, where the faces are 
centered and facing the camera. The more non-standardized conditions, the more 
difficulty the algorithm has correctly predicting accurately.  
 “Deep learning” attempts to address these two concerns, as the algorithms are 
designed to detect patterns within data that isn’t necessarily standardized to a high 
degree, and which may contain erroneous or confusing data. Deep learning algorithms, 
for instance, are able to take images of cats, facing towards and away from the camera, at 
different times of day, and predict that the image it is seeing is that of a cat. The 
erroneous data of lighting conditions or size can be ignored, because of the different way 
that deep learning is making its calculations.  
 In the case of a cat, there are near universal aspects of cats - pointed ears, eyes, a 
nose and mouth, a tail and four legs - that when put together, constitute a cat. The 
‘neurons’ (as mentioned above) for a Deep learning algorithm are designed to discover 
these smaller attributes, and then use that discovery to detect their presence in the data it 
is analyzing. If enough attributes of a cat are present, no matter the size or condition, the 
algorithm can recognize the presence of a cat in an image. The computational ability 
required to make this more complex analysis is far more significant, and the system is 
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more complex than a more traditional machine learning algorithm that does not collect a 
series of smaller attributes.  
 In theory, this is very applicable to EHR data, as EHR data is notoriously 
unstandardized. Many terms or shorthand phrases for the same condition differ from 
hospital to hospital, and some hospitals will have different protocols relating to, say, 
testing for sepsis. Handwritten doctor’s notes about a condition could vary greatly from 
doctor to doctor. In theory, the advent of deep learning gives the opportunity to detect 
patterns in spite of these inconsistencies.    
 Deep learning has seen relatively few published studies on sepsis recognition, 
possibly due to the relative newness of deep learning as an area of study. However, a few 
studies have seen interesting results. A study by Kam et al. used deep learning applied to 
the same MIMIC-II database as the Insight study. It found higher rates of reliable 
diagnosis, crediting, in part, a “neural network architecture that can learn sequential 
patterns.”70 Other studies in deep learning focused on another area of machine learning, 
known as reinforcement learning. 
REINFORCEMENT LEARNING 
In traditional ‘supervised’ machine learning, a data point is given with a ‘correct’ 
answer of what that data point means, and the machine learning algorithm is designed to 
learn the associations. There is also ‘unsupervised’ learning, in which a dataset is given 
with no clear association with what is ‘correct’, with machine learning algorithm 
attempting to find patterns in the data. Reinforcement learning is different from those 
two, in that it is designed to learn from interactions – that is, a reinforcement learning 
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algorithm that would make ‘decisions’, and see how well the decisions maximized a 
‘reward’ variable85 (such as patient mortality). This is analogous to the psychological 
concept of reinforcement learning,86 first made famous by Pavlov and his famous 
experiment on his dogs. 
A good example of this form of machine learning is a study by Cockrell, et al., 
which created a simulation of virtual sepsis patients, and a study by Peterson, et al. that 
used reinforcement learning to conduct experimental treatment ‘actions’ on the virtual 
patients. The algorithm would then learn how well its treatment actions would help the 
virtual patients, and adjust its treatments until they maximized patient health. 
Cockrell, et al. created a simplified model of 7 million virtual sepsis patients with 
a wide range of symptoms. The simulation, the Innate Immune Response Agent-Based 
Model (IIRABM), represents the dynamic of immune response, down to the temporary 
roles of pro- and anti-inflammatory cytokines.71 While the simulations were “vastly 
simpler” than a real-world sepsis patient, the use of simplified models allows for 
comprehensive testing when all variables are known, and any potential learning can then 
be applied to the more complicated real-world cases. The intent was to present a body of 
potential “patients” to study with High Performance Computing (HCP) models such as 
deep learning, to see if it was possible to create personalized diagnoses of sepsis, to aid in 
personalized treatments rather than generalized antibiotic regimens.71  
That study was then used by Peterson et al. to run a deep learning analysis. The 
analysis was designed to analyze if “adaptive, personalized multi-cytokine mediation can 
control the trajectory of sepsis and lower patient mortality.”72 The study used the 
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IIRABM as a Reinforcement Learning environment. The deep learning algorithm would 
make an action upon the IIRABM simulation, and would record how effective the result 
was on the population of simulated sepsis patients. It would then continue experimenting 
with actions until it found effective policies to reduce mortality as much as possible.  
Using this deep reinforcement learning model, the study was able to come to 0% 
mortality in simulated subjects. It created specific policies for patients that were 
personalized (patient-specific), involved mediating multiple cytokines simultaneously in 
coordination, and were adaptive to the virtual patient’s progress over time.72 While this is 
clearly a virtual system, and thus the results are not immediately generalizable to real-life 
patients, the model is instructive – it shows that deep learning can analyze large volumes 
of data to present a policy, which can then be tested more formally in clinical trials.  
Another study by Raghu et al. analyzed the MIMIC-III database with 
reinforcement learning.73 The MIMIC-III database represents patients that have already 
been treated, so dynamic actions on the populace are not possible. However, 
reinforcement learning could be used to “read” the medical interventions, and to 
understand how effective they were in maximizing the ‘reward’ of a healthy outcome (in 
this case, lowered SOFA scores). The benefit of using reinforcement learning is that the 
model can “infer optimal strategies from training examples that do not represent optimal 
behavior.”73 In observing patterns of sepsis treatment, it found an “optimal” vasopressor 
and IV fluid dose, arguing that lower mortality resulted from cases where physicians 
applied vasopressors and IV fluids in accordance to this optimal policy.73 More research 
would be required before this practice could be regularly applied in clinical settings, but 
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this does present a data-driven approach to answer the question of the optimal sepsis 
treatment policy. 
 
CLINICIAN DISTRUST AND ALGORITHMIC TRANSPARENCY 
With more advanced machine learning designs comes more computational ability, 
and as such, the ability to use more data to more accurately predict a condition like 
sepsis. However, the complexity also makes any attempt to ‘read’ or understand the inner 
workings significantly more complex. For instance, while a clinician may not be able to 
see the infrared detection of an pulse oximeter, and does not personally calculate the ratio 
of red to infrared light (which translates into a measure of blood oxygen saturation via the 
Beer-Lambert Law87), the doctor could personally calculate the ratio, and can understand 
that the system is reliably based on this specific input. Machine learning, on the other 
hand, is a form of guessing and statistical probablility assigned to diagnose life-or-death 
conditions such as sepsis. As such, there has been an increase in skepticism regarding 
machine learning’s somewhat random learning process. For instance, The research group 
AI Now published a 2017 report recommending that healthcare agencies should not use 
“black box” algorithms, as their use raises ‘serious due process concerns’.88  
An example of a machine learning algorithm making a logical, but problematic 
conclusion, was that of the relationship between asthma and pneumonia mortality.89 A 
researcher for Microsoft explained that in the 1990s, they had trained an algorithm to 
predict mortality probability for pneumonia patients, to separate low-risk from high-risk 
individuals. The intent was to place high-risk patients in higher priority for treatment. 
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The algorithm looked at prior data, and deduced that asthmatic patients had a lower 
probability of mortality from pneumonia, and were placed in the low-risk tier. However, 
this lower probability occurred because asthma is considered a serious risk factor for 
pneumonia. Asthmatic patients were quicker to bring themselves to treatment when 
noticing difficulty breathing, and patients presenting with a history of asthma were 
admitted more immediately.89 In other words, prioritizing asthmatic patients was what 
made the mortality rate decrease for these patients. The algorithm would have no way of 
knowing that, however, and the algorithm moving that classification of patient to the low-
risk tier would have removed that benefit. If an algorithm is not designed to be readable, 
this sort of deduction cannot be recognized by a supervisor and corrected, and could have 
dangerous results.  
Similarly, machine learning algorithms could make decisions based on 
information that is unethical, such as making triage decisions based on the ethnicity or 
gender of a patient, rather than on the patient’s condition.90 Part of this moral dilemma is 
being decided by legal systems - The recent General Data Protection Regulation (GDPR) 
passed by the European Union creates a “right to explanation,”91 where a user can ask for 
an explanation of how an algorithmic decision was made about them. In response to 
ethical and legal pressure, machine learning researchers have been designing algorithms 
to include interpretability. For instance, an algorithm could display text snippets related 
to information used to inform decisions, so that a supervisor could deduce what part of 
the data is being used to make a certain decision.92,93.  
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USABILITY AND ALARM FATIGUE 
While multiple researchers have used machine learning retroactively to analyze 
patient data and diagnose sepsis, there have been relatively few proactive clinical trials. 
While there is promise in conducting a retroactive trial, more research is needed into 
effective, repeatable clinical trials to strengthen the case of using Machine Learning-
Based Diagnostic Support Systems (ML-DSS) in the hospital setting. In addition to 
experiential robustness, an ML-DSS should also take care to integrate well into the 
clinical setting, rather than adding another burden for clinicians. 
One issue to consider is the potential to adding to alarm fatigue. Many electronic 
systems already present in an Emergency Department or Intensive Care Unit are 
equipped with alarms meant to alert staff about potential emergencies. The volume of 
alerts currently used can be immense – A study at UCSF found that in one month, more 
than 2.5 million alarms were raised, and that nearly half of these alarms were for a wildly 
inaccurate arrhythmia alert system. Of the 1.15 million arrhythmia alarms that were 
generated, more than 88% were false positives.94  
Interestingly, this problem has also attracted some interest from the machine 
learning community - a research group is using a machine learning system to find and 
suppress false alarms for arrhythmias.95 Researchers have reported that monitor alerts 
result in changes in patient management less than 1% of the time96due to the high volume 
of alarms that do not convey meaningful information – if an ML-DSS program is to be 
 45 
effective in the treatment of sepsis, it cannot simply add to the noise affecting clinicians 
in the hospital setting.   
Since standards for sepsis are controversial and not entirely standardized, there is 
also a possibility that an ML-DSS program could be making decisions based on older, 
outdated guidelines. Machine learning algorithms already face distrust by medical 
professionals due to the the “black box” nature of the algorithm’s decision process97 – if a 
standard for sepsis diagnosis or billing codes were to change in five years, and the 
machine is not updated for the new standards, this would only add to alarm fatigue, and it 
is likely that staff will be similarly dismissive of any new system, no matter how 
theoretically effective it might be.  
 
FUTURE IMPLEMENTATIONS 
Perhaps, with proper user experience design, an ML-DSS could be used to save 
time, as opposed to handing a clinician more responsibilities. For instance, upon sensing 
that a patient’s vital signs are leading towards possible sepsis, perhaps an ML-DSS could 
automatically order blood work for biomarkers such as PCT and CRP. If conditions 
continue to worsen, the system could automatically order tests for a more specific 
diagnosis, such as markers for the presence of certain bacteria. If a clinician then comes 
to assess the patient, a clear timetable of suspicions, of laboratory results and suspected 
pathogens could be presented to the clinician, simplifying the amount of steps needed to 
reach a diagnosis. The system could be designed such that alerts only present to clinicians 
once standard steps have been taken, reducing the workload for the clinician.  
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Machine learning algorithms have the ability to continuously process data at a 
level clinicians are unable to. As Taneja et al. found, machine learning algorithms can 
learn to prioritize certain biomarkers at certain stages, and predict the severity of sepsis 
due to this. Monitoring a comprehensive suite of biomarkers, especially if the ML-DSS 
could also automatically order blood tests, could provide a more clear picture, rather than 
simply alerting a clinician to the possibility of a diagnosis. It is possible that, if an ML-
DSS is designed with interpretability in mind, that the interface could display the 
reasoning for the actions it suggests taking, providing a sort of upgraded, commented lab 
result that a clinician could use to make decisions.  
Similarly, ML-DSS programs could be used to reduce patient rehospitalization. 
Rehospitalizations for patients with sepsis are mostly due to infection or another septic 
episode. After an index sepsis incident, nearly 40% of patients are transferred to skilled 
nursing facilities.33 Perhaps an ML-DSS program could be designed to communicate with 
facility systems to provide similar diagnostic support, and monitor for signs of infection, 
prompting recommendations for antibiotic treatment to be administered at the skilled 
nursing facility.  
CONCLUSION 
Sepsis is a complex, deadly disease, known since the time of Hippocrates.98 In the 
present day, it is one of the leading causes of mortality in the hospital setting. It is also not 
fully understood – pathologies of sepsis differ depending on the age of the patient and prior 
comorbidities, making diagnosis difficult. Bloodwork can’t paint a complete picture, as 
there’s no single biomarker that clearly delineates sepsis, and the most prevalently tested 
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biomarkers are chosen for laboratory availability rather than specificity. The very 
definition of sepsis in the medical community is controversial, subject to a major change 
in 2016, which is not universally accepted. Patient factors are also highly influential with 
respect to outcome and not always easily mineable from the chart. Patients that contract 
sepsis live with a severe symptoms, prone to re-hospitalization (often due to infection) and 
with a five times higher chance of mortality five years after the index event. Given the high 
cost of life and resources, there is a real need to address sepsis and minimize the loss of 
life and limb.  
Traditional computerized ‘alerts’ that monitor vital signs and notify clinicians of 
possible sepsis have been around for some time, but they are limited to only reporting a 
patient already in sepsis. Academic research has been investigating using machine 
learning to predict sepsis instead, and to increase the accuracy and timeliness of both 
sepsis diagnosis and treatment. The field has seen multiple promising studies, with 
algorithms that are reported to be equally as sensitive and specific as current diagnostic 
protocols such as SIRS and qSOFA. Some algorithms even propose new methods of 
detection and treatment, looking at a more granular level at the levels of individual 
cytokines on a continuous level, to guage how far along the condition of sepsis a patient 
is. These proposed algorithms have lots of promise for prediction, diagnosis and 
treatment, but more research needs to be conducted before these studies are to be seen in 
Emergency Departments around the world. Most of the studies conducted so far are 
retrospective studies done on EHR databases, and few prospective studies have been 
performed. However, this is not far off – one company, Dascena, has tested Machine 
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Learning-Based Diagnostic Support System (ML-DSS) called InSight in a live clinical 
trial. To the author’s knowledge, InSight is the only commercially available ML-DSS 
tool currently available, but more are likely to follow.  
A few complications need to be considered for an ML-DSS to be truly effective. 
An ML-DSS should be transparent and intuitive enough that a clinician can understand 
what the decisions are being based off of, so that the clinician can trust the software, and 
can check for erroneous assumptions that the algorithm is making. In addition, for true 
acceptance in a clinical setting, an ML-DSS should reduce, rather than add to, the alert 
fatigue that is currently present in hospitals. Adding another alert to the cacophony being 
given to a clinician will likely not help in the timely diagnosis and treatment of sepsis. 
However, if proper thought is put into the design of an ML-DSS for a clinical setting, and 
financial and logistical considerations are further developed, machine learning can have a 
powerful, useful, and ultimately life-saving role in the diagnosis and treatment of sepsis.  
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